Citadel Advisors »

Acelrx Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $32k 36k 0.89
2024-03-31 $43k 41k 1.03
2023-12-31 $22k 30k 0.74

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Citadel Advisors

Top funds holding Acelrx Pharmaceuticals

Nantahala Capital Management
Rosalind Advisors
Rock Springs Capital Management
MAI Wealth Advisors
Vanguard Group
Royal Bank of Canada
Geode Capital Management
Values First Advisors
BlackRock
Susquehanna International
Turtle Creek Wealth Advisors
Two Sigma Securities
Citadel Advisors
State Street Corporation
Tower Research Capital

View all funds holding Acelrx Pharmaceuticals